Zobrazeno 1 - 10
of 210
pro vyhledávání: '"Helong Zhang"'
Autor:
Shun Lu, Xiaorong Dong, Hong Jian, Jianhua Chen, Gongyan Chen, Yuping Sun, Yinghua Ji, Ziping Wang, Jianhua Shi, Junguo Lu, Shaoshui Chen, Dongqing Lv, Guojun Zhang, Chunling Liu, Juan Li, Xinmin Yu, Zhong Lin, Zhuang Yu, Zhehai Wang, Jiuwei Cui, Xingxiang Xu, Jian Fang, Jifeng Feng, Zhi Xu, Rui Ma, Jie Hu, Nong Yang, Xiangdong Zhou, Xiaohong Wu, Chengping Hu, Zhihong Zhang, You Lu, Yanping Hu, Liyan Jiang, Qiming wang, Renhua Guo, Jianying Zhou, Baolan Li, Chunhong Hu, Wancheng Tong, Helong Zhang, Lin Ma, Yuan Chen, Zhijun Jie, Yu Yao, Longzhen Zhang, Jie Weng, Weidong Li, Jianping Xiong, Xianwei Ye, Jianchun Duan, Haihua Yang, Meili Sun, Hongying Wei, Jiawei Wei, Zheyu Zhang, Qiong Wu
Publikováno v:
Cancer Communications, Vol 44, Iss 9, Pp 1005-1017 (2024)
Abstract Background The initial randomized, double‐blinded, actively controlled, phase III ANEAS study (NCT03849768) demonstrated that aumolertinib showed superior efficacy relative to gefitinib as first‐line therapy in epidermal growth factor re
Externí odkaz:
https://doaj.org/article/2b6ae05d34ee40d883ed46122a1d5428
Autor:
Likun Chen, Jose David Gomez Rangel, Timucin Cil, Xingya Li, Irfan Cicin, Yihong Shen, Zhihua Liu, Ozgur Ozyilkan, Bondarenko Igor, Jun Chen, Kostiuk Oleksandr, Zhendong Chen, Helong Zhang, Ziyi Fu, Qingfeng Dong, Shuqiang Song, Jin‐Chen Yu, Li Zhang
Publikováno v:
Cancer Medicine, Vol 12, Iss 22, Pp 20847-20863 (2023)
Abstract Background BAT1706 is a proposed biosimilar of bevacizumab (Avastin®). We aimed to compare the efficacy and safety of BAT1706 with that of EU‐sourced reference bevacizumab (EU‐bevacizumab) in patients with advanced nonsquamous non‐sma
Externí odkaz:
https://doaj.org/article/81f12a95ae2a40989aaa39d8ab3f0483
Publikováno v:
Agriculture, Vol 14, Iss 8, p 1376 (2024)
Stem mustard, the main raw material for pickled mustard tuber, is widely planted in Chongqing, China, and is an important local cash crop. Under the working conditions of sticky and wet soil in the Chongqing area, conventional furrow seeding has prob
Externí odkaz:
https://doaj.org/article/7c68f62b2c87422db6170804d12843cc
Autor:
Lili Liu, Tao Zhang, Xiang Song, Cheng-gong Liao, Tengyun Xu, Yang Yang, Ming Zeng, Junmei Jia, Haichuan Su, Yang Song, Jie Min, Hongmei Zhang, Wei Li, Hongwei Zhang, Helong Zhang
Publikováno v:
International Journal of Hyperthermia, Vol 40, Iss 1 (2023)
AbstractObjective To compare the efficacy and safety of hyperthermic intrathoracic/intraperitoneal chemotherapy versus conventional intrapleural/intraperitoneal chemotherapy in the treatment of malignant pleural or peritoneal effusion.Methods A rando
Externí odkaz:
https://doaj.org/article/af839dadd2b7467bad2c16b601982123
Autor:
Yuankai Shi, Jianhua Chen, Helong Zhang, Zhihong Zhang, Yiping Zhang, Zhehai Wang, Shucai Zhang, Jian Zhao, Chunling Liu, Xiuwen Wang, Yanqiu Zhao, Changlu Hu, Lei Yang, Xuezhi Hao, Lin Wang, Yunpeng Liu, Yan Yu, Jun Zhao, Mengzhao Wang, Liangming Zhang, Sanyuan Sun, Yanping Hu, Kangsheng Gu, Xiaosheng Hang, Jinlu Shan, Yu Zhang, Bangxian Tan, Weihua Yang, Runxiang Yang, Meimei Si, Huaize Geng, Hui Li, Xiaoyan Kang
Publikováno v:
BMC Medicine, Vol 21, Iss 1, Pp 1-12 (2023)
Abstract Background Iruplinalkib (WX-0593) is an anaplastic lymphoma kinase (ALK)/c-ros oncogene 1 (ROS1) tyrosine kinase inhibitor. Here we reported the single-arm, phase II study (INTELLECT) results of the efficacy and safety of iruplinalkib for AL
Externí odkaz:
https://doaj.org/article/fa1f8545777d42219ff4b4af29402825
Autor:
Lili Liu, Li Sun, Ning Zhang, Cheng-gong Liao, Haichuan Su, Jie Min, Yang Song, Xue Yang, Xiaofeng Huang, Dongxu Chen, Yu Chen, Hong-wei Zhang, Helong Zhang
Publikováno v:
International Journal of Hyperthermia, Vol 39, Iss 1, Pp 239-245 (2022)
Objective To investigate the efficacy and safety of a novel method of hyperthermic intraperitoneal chemotherapy (HIPEC) as adjuvant therapy for stage-III gastric cancer. Methods Patients with stage-III gastric cancer who underwent D2 radical gastrect
Externí odkaz:
https://doaj.org/article/be28926e47b74be18253fcb5f6da8666
Autor:
Hongbing She, Zhiyuan Liu, Zhaosheng Xu, Helong Zhang, Feng Cheng, Jian Wu, Xiaowu Wang, Wei Qian
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-12 (2022)
Abstract Spinacia is a genus of important leafy vegetable crops worldwide and includes cultivated Spinacia oleracea and two wild progenitors, Spinacia turkestanica and Spinacia tetrandra. However, the chloroplast genomes of the two wild progenitors r
Externí odkaz:
https://doaj.org/article/d9486e7d6a144fe790e1c94a1192a7a1
Autor:
Yuankai Shi, Jian Fang, Xuezhi Hao, Shucai Zhang, Yunpeng Liu, Lin Wang, Jianhua Chen, Yi Hu, Xiaosheng Hang, Juan Li, Chunling Liu, Yiping Zhang, Zhehai Wang, Yanping Hu, Kangsheng Gu, Jian’an Huang, Liangming Zhang, Jinlu Shan, Weiwei Ouyang, Yanqiu Zhao, Wu Zhuang, Yan Yu, Jun Zhao, Helong Zhang, Pei Lu, Weidong Li, Meimei Si, Mingjing Ge, Huaize Geng
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 7, Iss 1, Pp 1-10 (2022)
Abstract WX-0593 (Iruplinalkib) is a novel, highly selective oral ALK and ROS1 tyrosine kinase inhibitor (TKI). In this study, the safety, antitumor activity, and pharmacokinetics of WX-0593 were evaluated in advanced non-small cell lung cancer (NSCL
Externí odkaz:
https://doaj.org/article/63fd124f595044de8c643d52a5e2af70
Autor:
Tao Jiang, Pingyang Wang, Jie Zhang, Yanqiu Zhao, Jianying Zhou, Yun Fan, Yongqian Shu, Xiaoqing Liu, Helong Zhang, Jianxing He, Guanghui Gao, Xiaoqian Mu, Zhang Bao, Yanjun Xu, Renhua Guo, Hong Wang, Lin Deng, Ningqiang Ma, Yalei Zhang, Hui Feng, Sheng Yao, Jiarui Wu, Luonan Chen, Caicun Zhou, Shengxiang Ren
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 6, Iss 1, Pp 1-9 (2021)
Abstract This multicenter phase-II trial aimed to investigate the efficacy, safety, and predictive biomarkers of toripalimab plus chemotherapy as second-line treatment in patients with EGFR-mutant-advanced NSCLC. Patients who failed from first-line E
Externí odkaz:
https://doaj.org/article/7abdf0e3b19848238a658f5b4a0ed9c2
Autor:
Weineng Feng, Yufeng Wang, Fengming Ran, Yong Mao, Helong Zhang, Qifeng Wang, Wen Lin, Zhidong Wang, Jianli Hu, Wangjun Liao, Tao Zhang, Qian Chu, Weijie Xiong, Tienan Yi, Jiqun Yi, Shoucheng Ma, Yi Sun, Lingzhan Meng, Chunling Liu, Silang Zhou, Dengyun Zheng, Shubin Wang, Haifeng Lin, Wenzheng Fang, Jun Li, Minhui Wu
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
BackgroundOxycodone hydrochloride is a semisynthetic narcotic analgesic agent. This study aimed to explore optimal titration strategy of controlled-release (CR) oxycodone hydrochloride in patients with cancer pain.Methods258 patients, who used regula
Externí odkaz:
https://doaj.org/article/4fb43a3b309245c4a4004cb9ed669a7a